Hyundai Motor Group and Toray Group to develop advanced materials for future mobility, including high-performance vehicles and special-purpose mobilityHyundai Motor…
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses…
Latest release delivers native AI connectivity, behavioral analytics, and high-performance architecture for modern security operations INDIANAPOLIS and PARIS, Oct. 23,…
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…
WALTHAM, Mass., Oct. 15, 2025 /PRNewswire/ -- We are proud to announce that Advanced Instruments and Nova Biomedical are now…
INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old man with severe heart failure has been successfully…
October 08, 2025 09:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…
EXOSENS SECURES MAJOR CONTRACT WITH THE SPANISH ARMY FOR 17 000 ADVANCED NIGHT VISION MONOCULARS PRESS RELEASEMÉRIGNAC, FRANCE – SEPTEMBER, 29th…